lenalidomide has been researched along with Purpura, Thrombotic Thrombocytopenic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andreoli, A; Arnulf, B; Azoulay, É; Coppo, P; Elessa, D; Galicier, L; Harel, S; Joly, B; Lombion, N; Rigaudeau, S; Royer, B; Talbot, A; Veyradier, A | 1 |
| Cheah, CY; Manasanch, EE; Oo, TH; Orlowski, RZ | 1 |
2 other study(ies) available for lenalidomide and Purpura, Thrombotic Thrombocytopenic
| Article | Year |
|---|---|
Development of thrombotic thrombocytopenic purpura during lenalidomide therapy: three new cases and review of literature.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Female; Humans; Lenalidomide; Male; Middle Aged; Purpura, Thrombotic Thrombocytopenic | 2020 |
Thrombotic thrombocytopenic purpura in a patient with lenalidomide-responsive multiple myeloma.
Topics: Aged, 80 and over; Angiogenesis Inhibitors; Female; Humans; Lenalidomide; Multiple Myeloma; Purpura, Thrombotic Thrombocytopenic; Thalidomide | 2015 |